Top Markets
Coin of the day
AnnJi AnnJi

AnnJi

7754
Rang in Aktien #18684
Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co.,... Founded in 2014 and headquartered in Taipei, Taiwan, AnnJi Pharmaceutical Co., Ltd. specializes in the creation of innovative medicinal treatments. The company's research and development pipeline addresses neurological, dermatological, and inflammatory conditions. Among its key therapeutic candidates are AJ201, which is being developed for the neurodegenerative disorder spinal and bulbar muscular atrophy, and AJ202, targeting androgenetic alopecia. AnnJi also works on AJ302, a histone deacetylase 6 inhibitor aimed at preventing and treating chemotherapy-induced peripheral neuropathy, and AJ303, an anti-fibrotic and anti-inflammatory agent intended for idiopathic pulmonary fibrosis and other fibrotic diseases.
Aktienkurs
$1.88
Marktkapitalisierung
$190.02M
Veränderung (1 Tag)
0.51%
Veränderung (1 Jahr)
24.67%
Land
TW
Handel AnnJi (7754)

Kategorie

Kursverlauf für AnnJi (7754)
Höchster Schlusskurs: $1.76 am 2026-08-01

Niedrigster Schlusskurs: $1.35 am 2024-06-01
Kursverlauf der Aktie von AnnJi von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 10.35%
2025 60.82%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$121.62 -13.37%
AU
$764.47 7.08%
CH